Search research articles
Contact Us
Filters
Showing results (31-40 of 216) with videos related to
Page
of 22
Sort By:
Computers in Biology and Medicine
|
June 20, 2025
Assessing large language models for acute heart failure classification and information extraction from French clinical notes
Adrien Bazoge, Matthieu Wargny, Pacôme Constant Dit Beaufils, et al.
Diabetes & Metabolism
|
October 13, 2021
Do diabetic complications influence cancer-related events in people with type 2 diabetes? A cohort approach
Evelyne Liuu, Pierre-Jean Saulnier, Elise Gand, et al.
Nephrologie & Therapeutique
|
August 3, 2023
[How and when to use iSGLT2 (gliflozins) in clinical practice: a consensus for clinical practice proposed by the SFD, the SFC, the CNCF and the SFNDT]
François Diévart, Patrice Darmon, Jean-Michel Halimi, et al.
Kidney Medicine
|
February 29, 2024
Empagliflozin and Rapid Kidney Function Decline Incidence in Type 2 Diabetes: An Exploratory Analysis From the EMPA-REG OUTCOME Trial
Samy Hadjadj, Mark E Cooper, Dominik Steubl, et al.
Diabetes Care
|
January 29, 2020
Leukocyte Telomere Length, DNA Oxidation, and Risk of Lower-Extremity Amputation in Patients With Long-standing Type 1 Diabetes
Manuel Sanchez, Sophie Hoang, Caroline Kannengiesser, et al.
Diabetes Research and Clinical Practice
|
November 14, 2022
Renal function decline and heart failure hospitalisation in patients with type 2 diabetes: Dynamic predictions from the prospective SURDIAGENE cohort
Etienne Dantan, Maxime Pailler, Stéphanie Ragot, et al.
Diabetes & Metabolism
|
February 5, 2025
Lp(a) concentration and polymorphic size are not associated with new onset diabetes in individuals with prediabetes
Maxime Carpentier, Matthieu Wargny, Mikaël Croyal, et al.
Plos One
|
May 14, 2014
Manganese superoxide dismutase (SOD2) polymorphisms, plasma advanced oxidation protein products (AOPP) concentration and risk of kidney complications in subjects with type 1 diabetes
Kamel Mohammedi, Naïma Bellili-Muñoz, Fathi Driss, et al.
Diabetes Care
|
July 21, 2012
Prognostic value of resting heart rate on cardiovascular and renal outcomes in type 2 diabetic patients: a competing risk analysis in a prospective cohort
Aurelie Miot, Stéphanie Ragot, Wala Hammi, et al.
Kidney International Reports
|
December 19, 2022
Hemoglobin A1c Reduction With the GLP-1 Receptor Agonist Semaglutide Is Independent of Baseline eGFR: <i>post hoc</i> Analysis of the SUSTAIN and PIONEER Programs
David Z I Cherney, Samy Hadjadj, Jack Lawson, et al.
Page
of 22
Search research articles
Search
Showing results (31-40 of 216) with videos related to
Sort By:
Page
of 22
Computers in Biology and Medicine
|
June 20, 2025
Assessing large language models for acute heart failure classification and information extraction from French clinical notes
Adrien Bazoge, Matthieu Wargny, Pacôme Constant Dit Beaufils, et al.
Diabetes & Metabolism
|
October 13, 2021
Do diabetic complications influence cancer-related events in people with type 2 diabetes? A cohort approach
Evelyne Liuu, Pierre-Jean Saulnier, Elise Gand, et al.
Nephrologie & Therapeutique
|
August 3, 2023
[How and when to use iSGLT2 (gliflozins) in clinical practice: a consensus for clinical practice proposed by the SFD, the SFC, the CNCF and the SFNDT]
François Diévart, Patrice Darmon, Jean-Michel Halimi, et al.
Kidney Medicine
|
February 29, 2024
Empagliflozin and Rapid Kidney Function Decline Incidence in Type 2 Diabetes: An Exploratory Analysis From the EMPA-REG OUTCOME Trial
Samy Hadjadj, Mark E Cooper, Dominik Steubl, et al.
Diabetes Care
|
January 29, 2020
Leukocyte Telomere Length, DNA Oxidation, and Risk of Lower-Extremity Amputation in Patients With Long-standing Type 1 Diabetes
Manuel Sanchez, Sophie Hoang, Caroline Kannengiesser, et al.
Diabetes Research and Clinical Practice
|
November 14, 2022
Renal function decline and heart failure hospitalisation in patients with type 2 diabetes: Dynamic predictions from the prospective SURDIAGENE cohort
Etienne Dantan, Maxime Pailler, Stéphanie Ragot, et al.
Diabetes & Metabolism
|
February 5, 2025
Lp(a) concentration and polymorphic size are not associated with new onset diabetes in individuals with prediabetes
Maxime Carpentier, Matthieu Wargny, Mikaël Croyal, et al.
Plos One
|
May 14, 2014
Manganese superoxide dismutase (SOD2) polymorphisms, plasma advanced oxidation protein products (AOPP) concentration and risk of kidney complications in subjects with type 1 diabetes
Kamel Mohammedi, Naïma Bellili-Muñoz, Fathi Driss, et al.
Diabetes Care
|
July 21, 2012
Prognostic value of resting heart rate on cardiovascular and renal outcomes in type 2 diabetic patients: a competing risk analysis in a prospective cohort
Aurelie Miot, Stéphanie Ragot, Wala Hammi, et al.
Kidney International Reports
|
December 19, 2022
Hemoglobin A1c Reduction With the GLP-1 Receptor Agonist Semaglutide Is Independent of Baseline eGFR: <i>post hoc</i> Analysis of the SUSTAIN and PIONEER Programs
David Z I Cherney, Samy Hadjadj, Jack Lawson, et al.
Page
of 22